IRIS
DE LUCA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.353
NA - Nord America 10.065
AS - Asia 6.445
SA - Sud America 1.434
AF - Africa 145
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
Totale 29.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.863
RU - Federazione Russa 3.226
IE - Irlanda 2.799
SG - Singapore 1.871
CN - Cina 1.713
DE - Germania 1.532
HK - Hong Kong 1.175
UA - Ucraina 1.116
BR - Brasile 1.074
SE - Svezia 1.030
VN - Vietnam 901
FI - Finlandia 546
FR - Francia 473
IN - India 258
IT - Italia 226
GB - Regno Unito 161
AR - Argentina 135
CA - Canada 106
ID - Indonesia 87
MX - Messico 71
BD - Bangladesh 66
KR - Corea 65
EC - Ecuador 57
ZA - Sudafrica 51
IR - Iran 50
CO - Colombia 48
PL - Polonia 45
NL - Olanda 43
IQ - Iraq 41
PY - Paraguay 40
JP - Giappone 33
VE - Venezuela 33
ES - Italia 31
AT - Austria 28
TR - Turchia 27
PK - Pakistan 26
MA - Marocco 22
CL - Cile 21
BE - Belgio 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 16
PH - Filippine 15
KZ - Kazakistan 13
LT - Lituania 13
TN - Tunisia 13
EU - Europa 12
KE - Kenya 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
EG - Egitto 10
PE - Perù 10
UY - Uruguay 10
UZ - Uzbekistan 10
JO - Giordania 9
TH - Thailandia 9
BJ - Benin 8
IL - Israele 7
JM - Giamaica 7
AZ - Azerbaigian 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
AL - Albania 4
HU - Ungheria 4
LB - Libano 4
MD - Moldavia 4
AU - Australia 3
BO - Bolivia 3
BW - Botswana 3
BY - Bielorussia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
NG - Nigeria 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
KW - Kuwait 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CH - Svizzera 1
Totale 29.441
Salva come PNG Salva come JPEG
Città #
Dublin 2.798
Jacksonville 1.915
Hong Kong 1.172
San Jose 1.148
Dearborn 1.051
Singapore 732
Wilmington 701
Ashburn 552
Moscow 481
Beijing 458
Lawrence 382
Princeton 382
Lauterbourg 342
Ho Chi Minh City 301
San Mateo 261
Chandler 254
Los Angeles 225
Hanoi 176
Ann Arbor 168
Bremen 165
Andover 163
Buffalo 154
Council Bluffs 149
São Paulo 104
New York 83
Hefei 74
Dallas 73
Houston 73
Redondo Beach 70
Düsseldorf 67
Nanjing 66
Seoul 63
Santa Clara 61
Orem 60
Norwalk 54
Guangzhou 51
Woodbridge 51
Kunming 50
Munich 49
Tianjin 47
Haiphong 42
Rio de Janeiro 42
Piemonte 40
Frankfurt am Main 37
Nuremberg 37
Jinan 36
Leawood 36
Da Nang 35
Denver 35
Fairfield 35
Helsinki 34
Toronto 34
Monmouth Junction 33
Warsaw 33
Chennai 32
Hangzhou 31
Johannesburg 29
Mexico City 28
Tokyo 28
Montreal 27
Manchester 26
Seattle 26
Biên Hòa 25
Amsterdam 23
Ardabil 22
Chicago 22
Nanchang 22
Poplar 21
Shanghai 21
Shenzhen 21
Atlanta 20
Stockholm 20
Torino 20
Guayaquil 19
London 19
Phoenix 19
Brussels 18
Quito 18
Belo Horizonte 16
Brno 16
Bắc Ninh 16
Campinas 16
Columbus 16
Dong Ket 16
Hebei 16
Hải Dương 16
Jakarta 16
Rome 16
San Francisco 16
Boston 15
Brasília 15
Brooklyn 15
Curitiba 15
Guarulhos 15
Bexley 14
Boardman 14
Can Tho 14
New Delhi 14
Ribeirão Preto 14
Shenyang 14
Totale 16.627
Salva come PNG Salva come JPEG
Nome #
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 137
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 136
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 135
Mechanical reperfusion for STEMI: from randomized trials to clinical practice 132
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 130
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 130
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 128
P2Y12 inhibitors: pharmacologic mechanism and clinical relevance 128
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 126
Coronary intravascular ultrasound (IVUS): Contemporary applications and bases for the future 125
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 125
PCI techniques 124
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 124
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 124
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 123
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 122
ACC/AHA and ESC guidelines 121
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 119
Apical-sparing Tako-tsubo: A case report 119
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 119
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. 118
Switching from clopidogrel to prasugrel in patients having coronary stent implantation. 118
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 118
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 118
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 118
Adjuncitve pharmacotherapy: Anticoagulation 117
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 117
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 117
An unusual case of ECG ST-segment elevation 116
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 116
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 116
Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. 115
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 115
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 115
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 114
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 114
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 114
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 113
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 113
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials 112
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 112
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 111
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. 111
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 111
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 111
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 111
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 110
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 110
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 110
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 110
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 109
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. 109
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. 109
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 109
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 108
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 108
Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio 108
Redefining the success of mechanical reperfusion: ST-segment resolution 107
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 107
Antithrombotic therapies in primary angioplasty:rationale, results and future directions 107
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. 107
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 106
Direct coronary stenting: Effects on coronary blood flow, immediate and late clinical outcome 106
Impact of Preprocedural TIMI Flow on Myocardial Perfusion, Distal Embolization and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Angioplasty and Glycoprotein IIb/IIIa Inhibitors 106
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 106
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. 105
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 105
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 105
Pharmacological facilitation in primary angioplasty: myth or reality? 104
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 104
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 103
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. 103
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 103
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 103
A meta-analytic overview of thrombectomy during primary angioplasty 102
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 102
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 101
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. 101
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 99
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 99
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 99
Left ventricular angiography and other angiocardiographic techniques 98
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 98
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 98
Mechanical prevention of distal embolization: Rationale and trial results 97
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 97
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 97
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 97
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 96
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 96
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. 95
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 95
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 95
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 94
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 94
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 94
Balloon angioplasty or BMS? 93
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies 93
Early Glycoprotein IIb-IIIa Inhibitors in Primary Angioplasty- Abciximab Long-Term Results (EGYPT-ALT) Cooperation. An Individual Patients' Data Meta-Analysis. 93
Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials. 92
Totale 11.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.638
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/20222.083 72 54 302 135 200 8 163 35 155 60 385 514
2022/20234.395 412 147 211 54 246 262 81 193 2.640 8 87 54
2023/20241.236 65 71 78 18 279 2 225 20 3 9 188 278
2024/20252.968 55 29 98 21 70 387 280 234 936 350 62 446
2025/202611.333 364 374 1.088 1.920 737 819 1.866 1.999 743 788 519 116
Totale 30.219